Assertio Holdings Inc (ASRT)
1.00
+0.09
(+9.41%)
USD |
NASDAQ |
May 02, 13:45
Assertio Holdings Profit Margin (Quarterly): -174.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -174.0% |
September 30, 2023 | -784.6% |
June 30, 2023 | 20.66% |
March 31, 2023 | -8.20% |
December 31, 2022 | |
September 30, 2022 | 12.20% |
June 30, 2022 | 22.30% |
March 31, 2022 | 24.81% |
December 31, 2021 | 13.82% |
September 30, 2021 | 14.67% |
June 30, 2021 | -55.84% |
March 31, 2021 | 16.93% |
December 31, 2020 | -80.70% |
September 30, 2020 | -30.44% |
June 30, 2020 | -167.3% |
March 31, 2020 | |
December 31, 2019 | -325.2% |
September 30, 2019 | 6.04% |
June 30, 2019 | -23.78% |
March 31, 2019 | -24.69% |
December 31, 2018 | -56.66% |
September 30, 2018 | 62.29% |
June 30, 2018 | -33.26% |
March 31, 2018 | 26.34% |
December 31, 2017 | -35.07% |
Date | Value |
---|---|
September 30, 2017 | -16.76% |
June 30, 2017 | -26.54% |
March 31, 2017 | -29.57% |
December 31, 2016 | -35.81% |
September 30, 2016 | -11.67% |
June 30, 2016 | -9.03% |
March 31, 2016 | -19.96% |
December 31, 2015 | -27.59% |
September 30, 2015 | -11.24% |
June 30, 2015 | -22.91% |
March 31, 2015 | -36.12% |
December 31, 2014 | 48.62% |
September 30, 2014 | 12.54% |
June 30, 2014 | 18.82% |
March 31, 2014 | 23.44% |
December 31, 2013 | |
September 30, 2013 | 17.39% |
June 30, 2013 | 1.60% |
March 31, 2013 | -20.94% |
December 31, 2012 | -13.93% |
September 30, 2012 | -4.49% |
June 30, 2012 | -111.8% |
March 31, 2012 | -52.30% |
December 31, 2011 | -114.1% |
September 30, 2011 | -51.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-784.6%
Minimum
Sep 2023
24.81%
Maximum
Mar 2022
-89.34%
Average
-8.20%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
Ocular Therapeutix Inc | -197.4% |
Cormedix Inc | -- |
Verastem Inc | -- |
Puma Biotechnology Inc | 17.00% |
CytomX Therapeutics Inc | 3.15% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -156.3% |
Return on Assets | -87.36% |
Return on Invested Capital | -129.5% |
Gross Profit Margin (Quarterly) | 70.53% |
Operating Margin (Quarterly) | -19.68% |
Return on Net Operating Assets | -129.6% |